Inhibition of CD82 improves colitis by increasing NLRP3 deubiquitination by BRCC3

Kim, JS; Kim, HK; Lee, J; Jang, S; Cho, E; Mun, SJ; Yoon, S; Yang, CS

Yang, CS (通讯作者),Hanyang Univ, Dept Mol & Life Sci, Ansan 15588, South Korea.;Yang, CS (通讯作者),Ctr Bionano Intelligence Educ & Res, Ansan 15588, South Korea.

CELLULAR & MOLECULAR IMMUNOLOGY, 2023; 20 (2): 189

Abstract

CD82 is a transmembrane protein that is involved in cancer suppression and activates immune cells; however, information on the NLRP3 inflammasome is l......

Full Text Link